Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
ALLO
Stock Latest News
Company Announcements
Allogene Therapeutics’ Earnings Call: Progress Amid Challenges
5d ago
ALLO
Premium
The Fly
Allogene Therapeutics price target lowered to $4 from $8 at Citi
6d ago
ALLO
Premium
Ratings
Allogene Therapeutics: Strategic Cash Management and ALPHA3 Potential Drive Buy Rating Amid Clinical Delays
6d ago
ALLO
Premium
The Fly
Allogene Therapeutics price target lowered to $10 from $14 at Truist
7d ago
ALLO
Premium
The Fly
Allogene Therapeutics price target lowered to $9 from $10 at Oppenheimer
7d ago
ALLO
Premium
The Fly
Allogene Therapeutics price target lowered to $9 from $12 at Baird
7d ago
ALLO
Premium
Ratings
Buy Rating Affirmed for Allogene Therapeutics Amid Strategic Developments and Financial Strength
7d ago
ALLO
Premium
The Fly
Allogene Therapeutics price target lowered to $7 from $9 at Piper Sandler
7d ago
ALLO
Premium
Ratings
Positive Outlook on Allogene Therapeutics Amid ALPHA3 Trial Delays and Market Expansion Potential
7d ago
ALLO
Premium
The Fly
Allogene downgraded to Market Perform from Outperform at Citizens JMP
7d ago
ALLO
Premium
Company Announcements
Allogene Therapeutics Advances Clinical Trials and Extends Cash Runway
7d ago
ALLO
Premium
The Fly
Allogene Therapeutics reports Q1 EPS (28c), consensus (29c)
7d ago
ALLO
Premium
Pre-Earnings
ALLO Upcoming Earnings Report: What to Expect?
10d ago
ALLO
Premium
The Fly
Allogene Therapeutics to present updated ALLO-316 results at ASCO meeting
28d ago
ALLO
Premium
The Fly
Allogene Therapeutics granted three Fast Track Designations for ALLO-329
1M ago
ALLO
Premium
The Fly
Allogene Therapeutics participates in a conference call with JPMorgan
2M ago
ALLO
Premium
Ratings
Allogene Therapeutics: Buy Rating Backed by Promising Pipeline Developments and Strong Financial Position
2M ago
ALLO
Premium
The Fly
Allogene Therapeutics price target lowered to $8 from $9 at H.C. Wainwright
2M ago
ALLO
Premium
The Fly
Allogene Therapeutics management to meet virtually with Truist
2M ago
ALLO
Premium
Company Announcements
Allogene Therapeutics’ Earnings Call Highlights Progress
2M ago
ALLO
Premium
Ratings
Promising Pipeline and Upcoming Data Releases Drive Buy Rating for Allogene Therapeutics
2M ago
ALLO
Premium
The Fly
Allogene upgraded to Outperform from Market Perform at Citizens JMP
2M ago
ALLO
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
